SCHEMBL20394271

SCHEMBL20394271

COc1ccccc1-c1cccnc1Oc1cnc(OCc2ccccc2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
KDM4E B2RXH2 3/20 0.45
PDE10A Q9Y233 5/20 0.43
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
ELANE P08246 1/20 0.41
LTA4H P09960 1/20 0.41
MAPK14 Q16539 1/20 0.41
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TSHR P16473 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20406788 0.86 NPC1 (0.54) MAPTKDM4EPDE10APDGFRBELANE
SCHEMBL20394347 0.86 KDM4E (0.46) MAPTKDM4EPDE10APDGFRBPDGFRA
SCHEMBL20755033 0.82 CYP1A2 (0.53) KDM4EPDE10APDGFRBPDGFRACYP1A2
SCHEMBL20394473 0.81 PDE10A (0.42) PDE10AELANECYP1A2CYP3A4CYP2D6
SCHEMBL20394377 0.80 PDE10A (0.47) PDE10AELANETDP1ALDH1A1LMNA
SCHEMBL20394281 0.80 PDE10A (0.47) PDE10AELANEMEN1KMT2ATDP1
SCHEMBL20394225 0.79 HSD17B10 (0.46) MAPTKDM4EPDE10ACYP1A2CYP3A4
SCHEMBL20394226 0.79 PDE10A (0.47) MAPTKDM4EPDE10AELANECYP1A2
SCHEMBL20394304 0.79 GRM5 (0.47) MAPTKDM4EPDE10AELANETDP1
SCHEMBL20406721 0.78 PDE10A (0.44) KDM4EPDE10AELANECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351533-B1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMA CO LTD (JP) 2025-07-23 EP disclosed
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 US disclosed
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 US disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 EP disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647675-B2 Biaryl derivative and medicine containing same MAN2B1, CBR3, MANBA MAPT 4703/4885KDM4E 2642/4885PDE10A 4605/4885
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME MAN2B1, CBR3, MANBA MAPT 4703/4885KDM4E 2642/4885PDE10A 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.